BILLERICA, Mass.--(BUSINESS WIRE)--
Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader
insulin pump technology with its Omnipod® Insulin
Management System, today announced plans to release its financial
results for the fourth quarter and full year 2016 on February 27, 2017
after the close of the financial markets. In connection with the
release, management will host a conference call that day at 4:30 p.m.
The link to the live call will be available on the Investor Relations
section of the Company's website at http://investors.insulet.com,
"Events and Presentations", and will be archived for future reference.
You may also access the call by dialing (844) 831-3022 for domestic
callers or (315) 625-6887 for international callers, passcode is
55844501. A replay will be available two hours after the completion of
the call by dialing (855) 859-2056 (domestic) or (404) 537-3406
(international), passcode 55844501.
About Insulet Corporation:
Insulet Corporation (NASDAQ: PODD) is an innovative medical device
company dedicated to making the lives of people with diabetes easier.
Through its Omnipod Insulin Management System, Insulet seeks to expand
the use of insulin pump therapy among people with insulin-dependent
diabetes. The Omnipod is a revolutionary and easy-to-use tubeless
insulin pump that features just two parts and a fully-automated cannula
insertion. Insulet's Delivery Systems business also partners with global
pharmaceutical and biotechnology companies to tailor the Omnipod
technology platform for the delivery of subcutaneous drugs across
multiple therapeutic areas. Founded in 2000, Insulet Corporation is
based in Billerica, Massachusetts. For more information, please visit: http://www.myomnipod.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170123005766/en/
Deborah R. Gordon, 978-600-7717
President, Investor Relations and Corporate Communications
Source: Insulet Corporation
News Provided by Acquire Media